Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000711377-16-000072
Filing Date
2016-03-29
Accepted
2016-03-29 18:44:21
Documents
1
Period of Report
2016-03-24

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 2977
  Complete submission text file 0000711377-16-000072.txt   4273
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Issuer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address
Quinlan Steven J. (Reporting) CIK: 0001517426 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-17988 | Film No.: 161536651